Open Beta
TREN
MetriLume
TREN

US marketsIBIO

SEC-sourced researchBeta

IBIO

iBio, Inc.

Company comparison ↗

Data passport

CIK
0001420720
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 14, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: June 2025: 400,000.0000 USD; June 2026: 100,000.0000 USD400K USD0 USD0June 2025June 2026
IBIO · Exact amounts and source periods · USD
Period endRevenueFiling date
June 2025400,000.0000Aug 28, 2026
June 2026100,000.0000Aug 28, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
June 2026100,000.0000-33,044,000.0000-23,218,000.000099,110,000.000013,397,000.0000Aug 28, 2026
June 2025400,000.0000-18,377,000.0000-15,304,000.000023,185,000.00008,305,000.0000Aug 28, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$100KJune 2026Aug 28, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$400KJune 2025Aug 28, 202610-K
Net incomeNetIncomeLoss-$33.04MJune 2026Aug 28, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$23.22MJune 2026Aug 28, 202610-K
Total assetsAssets$99.11MJune 2026Aug 28, 202610-K
Total liabilitiesLiabilities$13.4MJune 2026Aug 28, 202610-K

New filings

Explore methodology ↗